Security key
34960Q307
Fortress Biotech, Inc. - Common Stock, par value $0.001 per share (FBIO)
CUSIP: 34960Q307
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 4,817,545
- Total 13F value
- $9,770,551
- Share change
- +359,155
- Put/Call ratio
- 267%
- SEC-reported price per share
- $2.02
- Number of holders
- 53
- Value change
- +$1,056,686
- Number of buys
- 29
- Number of sells
- 18
- Shares outstanding
- 33,557,755
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
53
Top holders
10
FBIO full security history
Ownership snapshot
Full 13F holder table
Fortress Biotech, Inc. SEC filings
Fortress Biotech, Inc. company facts
Fortress Biotech, Inc. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of FBIO - Fortress Biotech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 1.9%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 1.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
1.9%
Cambridge Investment Research Adv...
1.7%
Rosalind Advisors, Inc.
1.5%
ACADIAN ASSET MANAGEMENT LLC
1.4%
PVG ASSET MANAGEMENT CORP
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
1.9%
|
$903,203
625,054 shares
|
— | 30 Sep 2024 |
| Cambridge Investment Research Advisors, Inc. |
13F
Company
|
1.7%
|
$801,000
554,400 shares
|
— | 30 Sep 2024 |
| Rosalind Advisors, Inc. |
13F
Company
|
1.5%
|
$726,586
502,828 shares
|
— | 30 Sep 2024 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
1.4%
|
$696,000
482,595 shares
|
— | 30 Sep 2024 |
| PVG ASSET MANAGEMENT CORP |
13F
Company
|
1.1%
|
$540,127
373,790 shares
|
— | 30 Sep 2024 |
| SHIKIAR ASSET MANAGEMENT INC |
13F
Company
|
0.7%
|
$342,000
235,969 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
53
Shares
4,817,545
Rows available
53
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
49
Q4 2024 holders
53
Holder diff
4
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|